Biotech | April 06, 2022
MilliporeSigma acquires MAST platform from Lonza
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation
BioFluidica LiquidScan harnesses the power of microfluidics
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
The new facility is scheduled to start operation in the first half of 2024
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Announces pilot project for rapid, remote diagnosis of tuberculosis
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Subscribe To Our Newsletter & Stay Updated
